Jalen Duren says he wants to be a Piston for life despite contentious free agency, trade rumors

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-10-04 • Permanent link

Researchers at the Journal of Alzheimer's Disease have published a study revealing a disturbing correlation between glucosamine supplement users and an increased risk of mild cognitive impairment. According to the study, individuals who took these supplements were 25% more likely to experience mild cognitive impairment. This alarming finding has sent shockwaves through the health supplement industry, with major players such as Nature's Bounty and Jarrow Formulas facing scrutiny. Market analysts are predicting a significant decline in sales for these companies, with some estimating a 30% drop in revenue within the next quarter.

The implications of this study extend far beyond the health supplement industry, however. Investors who have sunk millions of dollars into these companies are now facing significant uncertainty about their returns. As a result, some investors are reevaluating their portfolios, seeking safer alternatives to mitigate potential losses. The broader economy is also at risk, as a decline in consumer spending on health supplements could have a ripple effect on the overall economy.

The health supplement industry has long been plagued by concerns about the safety and efficacy of its products. Glucosamine supplements, in particular, have been a subject of debate among experts, with some arguing that the benefits do not outweigh the risks. Since last quarter, the industry has seen a significant uptick in regulatory scrutiny, with the FDA launching several high-profile investigations into the safety of popular supplements. These developments have only added to the uncertainty surrounding the industry.

As the dust settles on this latest scandal, investors and consumers alike are left wondering what's next. Will the industry be able to recover from this latest blow, or will the damage be irreparable? In the coming weeks, we can expect to see a flurry of activity as companies scramble to respond to the study's findings and investors seek to reassess their portfolios. One thing is certain, however: the health supplement industry will never be the same again.